サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1374841

麻酔用気化器の世界市場 - 2023年～2030年

Global Anaesthesia Vaporizer Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 175 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
麻酔用気化器の世界市場 - 2023年～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 175 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

麻酔用気化器は、液体麻酔薬を気化させ、制御された量を患者に供給するために使用されます。濃度調整気化器には、可変バイパス、加熱ブレンダー、電子制御式ベーパーカセットの3種類があります。これらの装置は、手術室、救急部、分娩室、外傷部、外来手術センター、その他吸入薬剤の投与が必要なあらゆる場所で使用されます。ほとんどの場合、ヴェポライザーは麻酔器に取り付けられますが、特殊な取り付けブロックを使用することで、ヴェポライザーを人工心肺コンソールに取り付けることもできます。

気化器は麻酔装置の重要な一部です。これらの機器を適切に使用するためには、生理学と物理学を理解することが必要です。また、患者が軽い麻酔や痛みにさらされる可能性のある時間を減らすため、気化器の機能における問題を適時に認識することも不可欠です。

市場促進要因：市場抑制要因

技術進歩の上昇

精密投与や安全機能など、麻酔用気化器技術の進歩の高まりにより、ヘルスケアプロバイダーは機器のアップグレードを行うようになります。多くの進歩が発表され、予測期間中の市場成長に貢献しています。例えば、Zeus麻酔器に統合されたDrager DIVA気化器は、酸素、キャリアガス、麻酔蒸気の供給をクローズドループで定量制御し、ターゲット制御麻酔を可能にします。

さらに、手術件数の増加、病院や診療所の数の増加、老人人口の増加、医療費の高騰などの要因が、市場成長の原動力となっています。また、新興国における麻酔用気化器マスク市場の需要増加や、手術機器分野の研究開発により、予測期間中に新たなビジネスチャンスが生まれると予測されます。

市場力学：市場抑制要因

製品リコールは、消費者の信頼失墜や売上減少につながるため、麻酔用気化器市場に大きな影響を与える可能性があります。また、リコールは製造業者にとって法的・経済的な影響をもたらすこともあります。

例えば、2021年12月、Getinge社は、Flow Family Anesthesiaシステム用の特定のセボフルラン気化器に関連する世界の医療機器のリコールを発表しました。現在までのところ、患者や操作者の有害事象は報告されていないです。Getinge社は、適用される規制に従って関連当局に報告し、現在、現場安全通知/リコールを通じて、影響を受ける顧客にこの問題について通知しています。また、デバイスの高コストや規制上の課題は、予測期間中の市場成長率をさらに妨げると思われます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • テクノロジーの進歩
      • 高齢者人口の増加
    • 抑制要因
      • 製品リコール
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

  • プレナム気化器
  • ドローバー式気化器
  • Tec3気化器

第8章 薬剤別

  • 単一剤
  • 複数剤

第9章 エンドユーザー別

  • 病院
  • クリニック
  • 外来手術センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • GE Healthcare
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Medline
  • NANJING CHENWEI MEDICAL EQUIPMENT CO., LTD.
  • Dolphinmed
  • Conduct Science
  • Penlon
  • Dragerwerk AG & Co. KGaA
  • iClearhealthcare
  • Alnoor Medical
  • Harvard Apparatus

第13章 付録

目次
Product Code: MD7386

Overview

Anesthesia vaporizers are used to vaporize a liquid anaesthetic agent and deliver a controlled amount to the patient. There are three types of concentration-calibrated vaporisers variable bypass, heated blender, and electronically controlled vapor cassettes. These devices are used in operating rooms, emergency departments, delivery rooms, trauma departments, ambulatory surgical centres, and any areas requiring the administration of an inhalation agent. In the vast majority of cases, vaporizers will be mounted on anaesthesia machines; however, vaporizers can also be associated with cardiopulmonary bypass consoles by the use of special mounting blocks.

Vaporizers are an important part of anesthesia equipment. An understanding of physiology and physics is warranted to ensure the adequate use of these devices. The timely recognition of problems in vaporizer functioning is also essential, as this will decrease the amount of time that patients are potentially exposed to light anesthesia and pain.

Market Dynamics: Drivers and Restraints

Rise in the technological advancements

The rise in the advancements in anaesthesia vaporizer technology, such as precision dosing and safety features, attracts healthcare providers to upgrade their equipment. Many advancements have been released where it helps the market to grow during the forecast period. For example, The Drager DIVA vaporiser which is integrated into the Zeus anaesthesia machine allows for target-controlled anaesthesia with closed-loop quantitative control of the delivery of oxygen, carrier gas and anaesthetic vapour.

Furthermore, factors such as an increase in the number of surgeries, a rise in a number of hospitals and clinics, growth in the geriatric population, and high healthcare expenditure drive the market growth. The increase in demand for anesthesia vaporizer masks market in emerging nations and R&D in the field of surgical equipment is anticipated to create new opportunities during the forecast period.

Market Dynamics: Restraint

Product recalls can have a significant impact on the anesthesia vaporizer market, as they can lead to a loss of consumer confidence and a decrease in sales. They can also result in legal and financial consequences for the manufacturers.

For instance, in December 2021, Getinge stated a global medical device recall related to specific Sevoflurane vaporizers for Flow Family Anesthesia systems. To date, no patient or operator adverse events have been reported. Getinge has reported to relevant authorities according to applicable regulations and is now informing affected customers about the issue through a field safety notice/recall. Also high cost of devices, and regulatory challenges will further hamper the market growth rate during the forecast period.

Segment Analysis

The global anaesthesia vaporizer is segmented based on product type, agent-specific, end-user and region.

The Plenum Vaporizers from the product type segment accounted for approximately 41.2% of the market share

The plenum vaporizers from the product type segment accounted for approximately 41.2% and it is expected to be dominated during the forecast period. Plenum vaporizers are characterized by a pressurized vaporization chamber that generates an increased internal resistance (above atmospheric pressure) for fresh gas flow.

This type of vaporizer is currently the most commonly used and is characterized by its accuracy in the mixture of gases provided to the patient. It is not temperature-compensated. When the control knob, which is just a crude split ratio controller, is in the down position, the cowling over the U-tube descends and brings the FGF closer to the surface of the agent or forces it to bubble through the ether, increasing output by increasing the gas/liquid interface.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the strategic partnerships with key players, improved healthcare infrastructure, product launches by key players and others that will help this region to grow during the forecast period.

For instance, in April 2022, Respirair and Dechra confirmed the US Veterinary Anesthesia Partnership in the USA for isoflurane and sevoflurane veterinary vaporizers and anesthesia accessories. By supplying its market-leading, precision-engineered vaporizers, trolleys and accessories, in conjunction with Dechra's isoflurane and sevoflurane general inhalation anaesthetic agents, the collaboration seeks to create a powerful new force in veterinary anaesthesia coupled with proven, trusted and peerless quality delivery technologies.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the global anaesthesia vaporizer market and the COVID-19 pandemic has led to an increased demand for healthcare services, including surgeries and medical procedures, which has boosted the performance of the healthcare sector.

Also, during the pandemic over 20% of coronavirus victims suffered from acute respiratory distress syndrome needing lifesaving therapies in ICUs which led to enormous resource and infrastructure challenges. However, the crisis arguably created the perfect incubator for new ideas and accelerated innovation in anaesthesia vaporizers which helped the market to grow during the forecast period.

Market Segmentation

By Product Type

  • Plenum Vaporizers
  • Drawover Vaporizers
  • Tec3 Vaporizers

By Agent Specific

  • Single Agent
  • Multiple Agents

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the anaesthesia vaporizer market include: GE Healthcare, Medline, Nanjing Chenwei Medical Equipment Co., Ltd., Dolphinmed, Conduct Science, Penlon, Dragerwerk AG & Co. KGaA, iClearhealthcare, Alnoor Medical, Harvard Apparatus and among others.

Key Developments

  • In April 2022, GE Healthcare stated that the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anaesthesia delivery with end-tidal concentration control in the U.S. The company initially released the technology in Europe in 2010 and anesthesia providers use Et Control software to care for patients in over 100 countries.

Why Purchase the Report?

  • To visualize the global anaesthesia vaporizer market segmentation-based product type, agent-specific, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of anaesthesia vaporizer market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global anaesthesia vaporizer market report would provide approximately 61 tables, 57 figures, and 175 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Agent Specific
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. Rise in the technology advancements
      • 4.1.1.2. Rise in the geriatric population
    • 4.1.2. Restraints
      • 4.1.2.1. Product Recalls
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Plenum Vaporizers *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Drawover Vaporizers
  • 7.4. Tec3 Vaporizers

8. By Agent Specific

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 8.1.2. Market Attractiveness Index, By Agent Specific
  • 8.2. Single Agent *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Multiple Agents

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Agent Specific
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Medline
  • 12.3. NANJING CHENWEI MEDICAL EQUIPMENT CO., LTD.
  • 12.4. Dolphinmed
  • 12.5. Conduct Science
  • 12.6. Penlon
  • 12.7. Dragerwerk AG & Co. KGaA
  • 12.8. iClearhealthcare
  • 12.9. Alnoor Medical
  • 12.10. Harvard Apparatus

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us